P J Sellors, J J Kanski, D M Watson. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AdultAgedAnterior ChamberBlindness/etiologyEndopeptidases/therapeutic useEye Diseases/drug therapyFemaleHemorrhage/complicationsHemorrhage/drug therapyHumansMaleMiddle AgedSuppuration/complicationsUrokinase-Type Plasminogen Activator/administration & dosageUrokinase-Type Plasminogen Activator/therapeutic useVisual AcuityVitreous Body
Substances: See more » EndopeptidasesUrokinase-Type Plasminogen Activator
Year: 1974 PMID: 4534196
Source DB: PubMed Journal: Trans Ophthalmol Soc U K ISSN: 0078-5334